Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

9.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

13.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.7K
Rab Proteins01:14

Rab Proteins

5.4K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
5.4K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

10.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

6.2K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.8K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vps35 p. D620N causes Lrrk2 kinase hyperactivity, chronic microglial activation and inflammation.

bioRxiv : the preprint server for biology·2026
Same author

The Age at Onset of LRRK2 p.Gly2019Ser Parkinson's Disease Across Ancestries and Countries of Origin.

Annals of neurology·2026
Same author

Complementarity of Long-Reads and Optical Mapping in Parkinson's Disease for Structural Variants.

Annals of clinical and translational neurology·2026
Same author

A case report of multiple system atrophy-mimics: Importance of comprehensive evaluation in suspected familial cases.

Medicine·2026
Same author

Parkinson's disease LRRK2 mutations dysregulate iron homeostasis and promote oxidative stress and ferroptosis in human neurons and astrocytes.

bioRxiv : the preprint server for biology·2026
Same author

Clinical Features of Families with a Novel Pathogenic Mutation in Sepiapterin Reductase.

International journal of molecular sciences·2025
Same journal

Genetic Impacts on Variability of Body Fat Distribution Uncover Gene-Environment and Gene-Gene Interactions.

bioRxiv : the preprint server for biology·2026
Same journal

16S ribosomal RNA modification drives transcript-specific translation efficiency.

bioRxiv : the preprint server for biology·2026
Same journal

FlcE latches onto the FliL-stator complex to turbocharge flagellar motility in <i>Borrelia burgdorferi</i>.

bioRxiv : the preprint server for biology·2026
Same journal

Synaptic pruning, myelination and the emergence of psychiatric disorders in late adolescence.

bioRxiv : the preprint server for biology·2026
Same journal

Structural and functional insights into the Rcs phosphorelay.

bioRxiv : the preprint server for biology·2026
Same journal

The structural basis of RanGAP1 regulation and catalysis in nuclear transport.

bioRxiv : the preprint server for biology·2026
See all related articles

Related Experiment Video

Updated: Mar 19, 2026

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
12:49

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Published on: March 21, 2020

8.1K

Peripheral inflammation mediates midbrain Lrrk2 kinase activity via Rab32 expression.

Jordan Follett, Isaac Bul Deng, Robert C Sharp

    Biorxiv : the Preprint Server for Biology
    |March 18, 2026
    PubMed
    Summary
    This summary is machine-generated.

    Peripheral inflammation triggers Rab32 expression in microglia, activating Lrrk2 kinase. This pathway links inflammation to Parkinson's disease risk, highlighting Rab32/Tfe3 as potential therapeutic targets.

    More Related Videos

    Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
    08:55

    Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

    Published on: December 14, 2017

    16.2K
    Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
    11:31

    Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

    Published on: September 18, 2013

    10.5K

    Related Experiment Videos

    Last Updated: Mar 19, 2026

    Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
    12:49

    Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

    Published on: March 21, 2020

    8.1K
    Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
    08:55

    Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

    Published on: December 14, 2017

    16.2K
    Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
    11:31

    Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

    Published on: September 18, 2013

    10.5K

    Area of Science:

    • Neuroscience
    • Molecular Biology
    • Immunology

    Background:

    • Mutations in leucine-rich repeat kinase 2 (LRRK2) increase Parkinson's disease (PD) risk, but incomplete penetrance indicates other factors are involved.
    • Rab32 Ser71Arg was recently identified as a Mendelian gene for PD, suggesting a role for Rab32 in disease pathogenesis.

    Purpose of the Study:

    • To establish Rab32 as a mediator linking peripheral inflammation to Lrrk2 activation in Parkinson's disease.
    • To investigate the role of Tfe3 in regulating Rab32 expression and Lrrk2 activity during inflammation.

    Main Methods:

    • In vivo studies using lipopolysaccharide (LPS) to induce peripheral inflammation in mice.
    • Analysis of Rab32 expression in microglia and dopaminergic neurons.
    • Utilizing human induced pluripotent stem cell-derived microglia to assess species-conserved responses.
    • Promoter analysis to identify regulatory elements controlling Rab32 expression.
    • Investigating the nuclear translocation of Tfe3 in response to inflammation.

    Main Results:

    • Peripheral LPS-induced inflammation selectively increased Rab32 expression in midbrain microglia, correlating with Lrrk2 kinase activity.
    • LPS induced Rab32 expression in human microglia, indicating a conserved inflammatory response.
    • Tfe3 was identified as a key driver of LPS-induced Rab32 expression and Lrrk2 activation.
    • Tfe3 nuclear translocation in microglia during inflammation enhanced Rab32 expression and Lrrk2 activity.
    • Knockdown of Tfe3 mitigated inflammation-induced Rab32 expression and Lrrk2 activation.

    Conclusions:

    • Rab32 acts as a crucial mediator linking peripheral inflammation to Lrrk2 activation in Parkinson's disease.
    • The Rab32/Tfe3 pathway represents a novel mechanism by which inflammation modulates Lrrk2 activity.
    • Targeting Rab32 and Tfe3 offers a potential therapeutic strategy for neuroprotection in Parkinson's disease.